IIPLA News
Sunday, May 17, 2026

USPTO Director Clarifies Discretionary Standards in Denying Inter Partes Review in Magnolia Medical Case

Precedential decision underscores the Director’s role in balancing public interest and procedural integrity under the America Invents Act

IIPLA News Deskanonymous access0 articles left this week
USPTO Director Clarifies Discretionary Standards in Denying Inter Partes Review in Magnolia Medical Case
Sign In To Continue

You have reached the guest article limit.

Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.

In a significant precedential ruling, the USPTO Director articulated the discretionary framework guiding institution decisions for America Invents Act (AIA) reviews, including inter partes reviews (IPRs). The decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc. emphasizes considerations such as public intere…
Share This Article
Ready-to-post copy includes the article link.

USPTO Director Clarifies Discretionary Standards in Denying Inter Partes Review in Magnolia Medical Case In a significant precedential ruling, the USPTO Director articulated the discretionary framework guiding institution decisions for America Invents Act (AIA) reviews, including inter partes reviews (IPRs). The decision i... Read the full IIPLA article: https://iipla.org/news/uspto-director-clarifies-discretionary-standards-in-denying-inter-partes-review-in-magnolia-medical-case

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsUSA

Maryland Moves to Acquire Preakness Stakes Intellectual Property for $85 Million

Maryland Governor Wes Moore announced the state will match Churchill Downs’ $85 million bid to purchase the intellectual property rights to the Preakness Stakes and Black-Eyed Susan Stakes. The acquisition will be financed through 30-year bonds issued by the Maryland Economic Development Corporation, with debt service…

Thursday, June 18, 2026